StockData
Prime Medicine, Inc. logo

Prime Medicine, Inc. (PRME) stock

PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$3.82−0.02 (-0.52%)

Close on Nov 18, 2026Market cap $692.86MP/E –Yield –

Prime Medicine profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Prime Medicine's profit margin for the twelve months ending Dec 31, 2025 was -4342.4%. For fiscal 2025 it was -4342.4%, against -6566.6% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-4342.4%+2224.2
FY2024Dec 31, 2024-6566.6%−6501.2
FY2020Dec 31, 2020-65.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-5498.7%−3562.1
Q3 FY2025Sep 30, 2025-4129.1%+20999.1
Q2 FY2025Jun 30, 2025-4716.7%+3026.3
Q1 FY2025Mar 31, 2025-3568.8%–
Q4 FY2024Dec 31, 2024-1936.6%–
Q3 FY2024Sep 30, 2024-25128.2%–
Q1 FY2024Mar 31, 2024-7743.0%–

More Prime Medicine figures

See a number that looks wrong?